Burzynski Page #4

through all that intense high-dose chemo

and miss out on what might be the last bit of time

that we have with her, because I had talked to my uncle

-he's in his 60's now, but in 1969-

my cousin-his daughter was three years old

and she got cancer of some kind.

He told me about what that was like in that time.

They just kept giving her more chemo,

and more chemo, and more chemo,

and then finally we had this long

several-hour conversation one day and he told me,

I asked him because I was trying to prepare myself, I said,

"what was it like when a doctor tells you, that's it.

We can't do any more."

My uncle Ray told me that for the last few weeks

of my cousin's life, they celebrated Christmas once a week.

They had a Christmas and a birthday once a week until that was it.

I was putting myself in his shoes,

and I was just thinking,

I couldn't watch my daughter whither away,

and at least I wanted whatever time I had to be happy.

As happy as could be anyway.

And not just watch her whither away from chemo

that's not doing any good any more.

We had actually asked the endocrinologist

at M.D. Anderson about Dr. Burzynski,

he told us "he was a quack, and that

there was no evidence that it worked"

but at that point I was like

"well, yours doesn't really work either."

The other thing that I did, on the FDA's website

you can look up the day that which any drug

was granted FDA approval

and I realized that the oldest drug they wanted

to give Kelsey had come out in the early 1970's...

the newest drug they wanted to give

Kelsey came out around 1988...

and I realized, this isn't the cutting edge of technology,

they're giving us the same old stuff ...

I just thought, well, this is ridiculous.

It felt to me like they were grasping at straws.

I was doing all that research and

Sarah and Susan found the Burzynski Clinic.

Sarah said "l want to take her there."

I looked at it like, well,

if she's only got approximately 9 months to live,

and we come over here and we don't have all the side-effects...

well, in 9 month's time,

which am I going to be better off doing?

If the ending result is the same?

Upon the removal of Kelsey's left kidney and left adrenal gland,

her diagnosis was confirmed at the

University of Texas Medical Branch,

and again at M.D. Anderson cancer center.

Where, a month later, M.D. Anderson also confirmed

that Kelsey's cancer had spread to her lungs.

After desperately researching Kelsey's situation,

her family decided to decline all chemotherapy

treatments offered by M.D. Anderson,

and instead, enroll Kelsey into one of

Dr. Burzynski's clinical trials.

By this time, Kelsey's cancer had also spread into her liver.

After starting her Antineoplaston treatment,

the tumor in Kelsey's liver was gone by August of 2007.

CT scans of her chest revealed six tumors

in her lungs at the start of treatment.

One-by-one, the tumors in Kelsey's lungs began to go away

leaving one small spot four years later which

was deemed to be inactive and most likely scar tissue.

Today, Kelsey Hill is considered to have had a

complete response to her Antineoplaston treatment.

Since Dr. Burzynski began treating cancer patients

with Antineoplastons, he has successfully treated

virtually every type of cancer

relieving thousands of families from across the world

of this dread disease.

Yet, unlike other clinical trials which are supported by

billion-dollar pharmaceutical companies,

and are often assisted by large tax-funded research grants

from the National Cancer Institute,

the United States government currently prohibits any

tax-payer money to be granted to Dr. Burzynski's

FDA-approved clinical trials.

A single Phase 3 trial will cost about twenty-five million dollars.

So how many can you run?

You can run few at best.

Nobody is giving me any money for that,

we have to make money for that

-and it's twenty-five million dollars.

Some other pharmaceutical companies, who come with an idea, they

go to the National Cancer Institute and they receive a handsome grant

-fifteen million dollars, whatever, and they do clinical trials.

No one is giving me any money, okay?

I am working like in a war-time condition,

-when the bombs are falling, we still have to treat patients,

and we still have to do Phase 2 clinical trials.

Given the existence of a treatment that is curing cancer at a

rate that traditional medicine could only dream of,

and doing so without any damaging side-effects,

most would assume that every penny of our tax dollars allocated

for cancer research would be thrown in Dr. Burzynski's direction.

The problem that we face however, is that

a huge financial house has been built on the paradigm of

purging the body of cancer cells.

Burzynski's discovery, means that the foundation, the walls,

and the roof of that house, need to be replaced.

Think about it, we've got thousands of doctors in oncology,

and in oncology residency programs,

we've got the pharmaceutical industry pumping out

chemotherapeutic agents every month.

There are all kinds of machines that deliver radiation

we've got all this stuff in the war on cancer,

and it's trillions of dollars.

I find it very interesting that we have all

these walks for the cure of cancer.

We've got all the wristbands,

we've got all the donations-

"we're going to find a cure in this decade."

All this money keeps pouring in-

and it all goes to the same guys.

The pharmaceutical industry is arguably the most

profitable industry on our planet,

with it's profits being triple that of all of the Fortune 500 companies.

Rising profits result in rising stock prices, the only

way this industry can sustain this profitable momentum is by

continuing to introduce new patented drugs.

And since the pharmaceutical industry relies on the

FDA as it's gatekeeper to introduce these new drugs,

it's in their best interest to insure the

FDA remains as compliant as possible.

And since the FDA is also an office of the United States

government, it's in the government's best interest to preserve

one of its most powerful industries.

The former editor-in-chief of the New England Journal of Medicine,

Dr. Marcia Angell, has been very outspoken with the idea that:

"it's time to take the Food and Drug Administration

back from the drug companies."

In 1992, Congress put the fox in the chicken coop.

It passed the Prescription Drug User Fee Act, which authorizes

drug companies to pay "user fees" to the FDA for each

brand-name drug considered for approval.

The user fee act put the FDA on the

payroll of the industry it regulates...

and it has drastically changed the way it operates.

The part of the agency that reviews new drugs now gets more than

half of its money from the pharmaceutical industry.

The FDA's coziness with industry is underscored

by the composition of it's 18 advisory committees-

outside experts who help evaluate drugs.

Incredibly, many of these advisers work as

Rate this script:0.0 / 0 votes